We describe a simple liquid-chromatographic system for simultaneously measuring bronchodilators, anticonvulsants, hypnotics, and chioramphenicol. Use in therapeutic drug monitoring includes determination of theophylline, caffeine, chioramphenicol, ethosuximide, primidone, phenobarbital, phenacemide, phenytoin, mephenytoin, nirvanol, and carbamazepine and its bioactive metabolites within 13 mm. In the "toxicology mode" theophylline, caffeine, barbital, butabarbital, pentobarbital, amobarbital, secobarbital, primidone, 
drugs.
Kushida et al. (11) described a hiquid-chromatographic method for simultaneously quantifying phenobarbital, primidone, carbamazepine, phenytoin, and chloramphenicol, but the run-time of that system was too long for only five drugs. Ou and Rognerud (12) reported a very attractive method for microdetermination of seven anticonvulsants, their bioactive metabolites, chioramphenicol, and pentobarbital within 10 mm, but peaks for primidone and carbamazepine-diol overlapped, and the column life was relatively short. Recently, Meatherall and Ford (13) 
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Apparatus
(300 mg/L), and methaqualone (300 mg/L). These two combined standards were also added to drug-free sera to prepare the working standards and controls. Tolylphenobarbital (10 mg/L, in 0.2 mol/L hydrochloric acid) was the internal-standard working solution. Microcolumn for sample preparation.
Plug the tip of a 1-mL "Eppendorf"-type pipette with a small amount of glass wool or cotton, ff1 the low conical part with about 100 mg of Chromosorb PINAW, and place the so-prepared column on a stand, above an appropriate-size glass collection tube. Monitor the column effluent at 208 nm. Construct the calibration curves in "internal standard" mode and calculate unknowns from peak height or peak area ratios. Divide the values for plasma-water samples by 2 to account for the difference in sample volume.
Results and Discussion Figure 1 shows separate chromatograms for serum standards containing the TDM mode analytes and the POX mode analytes. All peaks are gaussian, which facilitates quantification.
The TDM mode takes 13 mm to resolve as many as 13 drugs and metabolites; POX mode separation requires 17 mm for 17 compounds. Retention times and capacity factors are listed in Table 1 . Theophyhhine and caffeine are always sufficiently separated from the solvent front despite the low wavelength of detection, and the accuracy and precision of their quantification are acceptable.
Note the overlaps between peaks for barbital and ethosuximide, fenacemide and methyprylon, chloramphenicol and butabarbital, which is the only reason to perform separate calibration in TDM and POX modes. A slightly modified mobile phase (340 mL of acetonitrile and 1660 mL of water) will resolve these three pairs of compounds, but increases the run times to 26 and 36 mm for both modes. Because these interferences are very unusual and unlikely to occur clinically, we prefer the faster mode of separation presented here; in case of analytical uncertainty, we use dual-wavelength monitoring without changing the mobile phase.
Other 
tolyiphenobarbital (internalstandard),(4) carbamazeplne >0.998. The slopes of these plots ranged from 0.921 to 1.08. Table 1 lists performance characteristics of this method. The extraction efficiency was calculated to measure the loss during sample pretreatment as follows: peak area of each drug from serum-derived chromatogram was divided by the peak area of the same concentration of the drug in mobile phase, directly injected for chromatography.
High extraction efficiency is one of the benefits of our microcolumn technology for sample preparation and our use of a greater proportion of isopropanol in the extraction mixture than used by others. The analytical recoveries of drugs added to human sera were calculated according to the formula:
100, and found to be 94-106% for the 21 drugs tested. The precision data were obtained by replicate measurements of drug-supplemented sera, serum pools, and commercial therapeutic drug controls in at least three concentrations: level I, subtherapeutic or free-drug concentrations; level II, the therapeutic range; and level Ill, toxic or lethal drug concentrations. The within-run CVs (n = 20) were <5.6%; the between-run CVs were <6.9%. The lower limits of detection (i.e., 0.02 A full scale) were between 0.05 and 0.1 mgfL.
Discussion
During the method development we have introduced (a) a unique microcolumn for sample pretreatment, (b) simultaneous determination of a wide variety of chemically and therapeutically unrelated drugs and their bioactive metabolites, (c) isocratic elution with unbuffered mobile phase, and (d) use of identical conditions of analysis for therapeutic drug monitoring and toxicology, all of which have resulted in several advantages and benefits.
Use of a Chromosorb P microcolumn for sample preparation is simple and cost-effective, and provides excellent purification. Only three pipettings and a few minutes for evaporation are required before chromatography. The amount of Chromosorb P is accommodated to the sample volume such that the aqueous phase (sample plus internal standard) moistens only the upper half of the column filling, where the extraction takes place. The low part remains dry and serves as a hydrophilic trap for the organic extractant, thus purifying it. Finally, the glass wool or cotton plug plays the role of a filter. Thus the sample is extracted, purified, and filtered as it passes through the column bed. Pretreatment of a single specimen takes about 10 mm; a batch of 20 samples can be prepared for chromatography in 30 min. This column procedure is universally quite useful, and we have applied it to analysis for a wide variety of endogenous substances and drugs by gas chromatography and liquid chromatography (unpublished data).
The ability to simultaneously determine theophylline, caffeine, chloramphenicol, and 10 anticonvulsants and metabolites in a single run provides versatility and convenience for the routine TDM laboratory, with only one instrument.
Moreover, this method resolves both carbamazepine epoxide and carbamazepine diol. Further expansion of the drug spectrum allows the additional determination of some important analytes for the clinical toxicology. When the instrument is calibrated for TDM assays and a stat toxicological analysis is administered, it is possible to extract and chromatograph the toxicological specimen immediately with an appropriately extended run-time.
The presence of uncalibrated analytes is reported as "yes" or "no"; if quantitative information is needed, the sample is reanalyzed after calibration for TOX mode. Use of pure water/acetonitrile mobile phase, without salts, is very convenient and protective for the analytical column and the chromatographic system as a whole; actually the instrument is "purged" during analysis. In our laboratory, we recycled 2 L of mobile phase for two months with no need for column equilibration or rinse time after each day's use. The system is rinsed with acetonitrile (700 mLIL) only when the mobile phase is changed. This method has been used in our laboratory for more than a year, for analysis of >2000 patients' samples, with no sign of column deterioration.
The procedure is applicable to the analysis of serum, plasma, plasma water, saliva, and other biological materials without any modification in sample pretreatment or chromatography. The overall performance characteristics well meet the requirements for routine TDM and toxicology assays. At least 25 specimens can be assayed and reported in a normal day, and 60 can be processed overnight with the equipment running unattended.
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